Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 37917058

Antitumor Activity and Safety of Dostarlimab Monotherapy in Patients With Mismatch Repair Deficient Solid Tumors: A Nonrandomized Controlled Trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
JAMA Netw Open
Publication date
2023 Nov 1
First author
André T

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      André T
      type
      Author
    2. name
      Berton D
      type
      Author
    3. name
      Curigliano G
      type
      Author
    4. name
      Sabatier R
      type
      Author
    5. name
      Tinker AV
      type
      Author
    6. name
      Oaknin A
      type
      Author
    7. name
      Ellard S
      type
      Author
    8. name
      de Braud F
      type
      Author
    9. name
      Arkenau HT
      type
      Author
    10. name
      Trigo J
      type
      Author
    11. name
      Gravina A
      type
      Author
    12. name
      Kristeleit R
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      André T
      type
      Author
    2. name
      Berton D
      type
      Author
    3. name
      Curigliano G
      type
      Author
    4. name
      Sabatier R
      type
      Author
    5. name
      Tinker AV
      type
      Author
    6. name
      Oaknin A
      type
      Author
    7. name
      Ellard S
      type
      Author
    8. name
      de Braud F
      type
      Author
    9. name
      Arkenau HT
      type
      Author
    10. name
      Trigo J
      type
      Author
    11. name
      Gravina A
      type
      Author
    12. name
      Kristeleit R
      type
      Author
    bibliography ids
    1. nci-bib-f028687dedd8c1e7b2b5ff90
    book metadata
    content sha256
    05e980c53c9ef70776dc9763e38d2ea31b8df20c00140d996663edff5f1efb94
    document type
    citation
    dois
    1. 10.1001/jamanetworkopen.2023.41165
    electronic publication date
    display
    2023 Nov 1
    precision
    day
    year
    2023
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:37917058
    immutable id
    pubmed:37917058@05e980c53c9ef70776dc9763e38d2ea31b8df20c00140d996663edff5f1efb94
    journal
    abbreviation
    JAMA Netw Open
    issn electronic
    2574-3805
    issn print
    Source null
    issue
    11
    name
    JAMA network open
    nlm unique id
    101729235
    pages
    e2341165
    volume
    6
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      37917058
      provenance
      batch id
      6d213eecf21b6b7867cb
      provider
      NCBI PubMed ESummary
      record sha256
      38798e82d37f28bf275087b958503df02ba7e1ed2fdcd541b5834211721603d6
      response sha256
      684f894a21d8f5f78a3bd0acd8ee4215ff94144487c53dab1056650ee8d6751d
      retrieved at
      2026-09-09T23:48:19.049083+00:00
      publication date
      display
      2023 Nov 1
      precision
      day
      year
      2023
      publication types
      1. Controlled Clinical Trial
      2. Multicenter Study
      3. Journal Article
      4. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/37917058/
      title
      Antitumor Activity and Safety of Dostarlimab Monotherapy in Patients With Mismatch Repair Deficient Solid Tumors: A Nonrandomized Controlled Trial.

      Preserved source evidence · Independent clinical review pending · Not medical advice